CD96 and neoplasm: The expression levels of immune checkpoint genes, including CTLA4, CD96, and TIGIT, were also enriched in the first layer (0–250 μm) on the tumor side, indicating an elevated immunosuppressive status of immune cells in this area (Fig. 3e; Materials and methods).